biotechNew
Xaira Therapeutics
AI-first drug discovery built on generative biology
weight 0.0Flux 62▴PaidLaunched 2026-06
💸 No earnings reported yet
What it is
Heavily funded biotech (launched with ~$1B) combining generative AI models — including RFdiffusion-lineage protein design from David Baker's lab — with large-scale data generation to discover medicines.
How AI plugs in
Generative and predictive AI across molecular design and target biology drive the full discovery pipeline.
Alternatives & related tools
BiotechImage / Video Models
Chai Discovery
New
Frontier biomolecular structure-prediction models
Science
BiotechResearch
Cradle
New
Generative AI protein engineering for the lab
Science
BiotechImage / Video Models
EvolutionaryScale
New
ESM3 frontier protein language model
Science
BiotechImage / Video Models
Generate Biomedicines
New
Generative biology platform designing novel protein therapeutics
Science
BiotechImage / Video Models
Profluent
New
AI protein and gene-editor design with atomistic control
Science
BiotechData & Analytics
Insilico Medicine
New
End-to-end AI drug discovery from target to clinic.
Science
★ Reviews
No reviews yet — be the first.Your rating